Katja Fink Selected Research

Viremia

12/2016	Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
1/2016	Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees.
2/2014	Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir.
4/2009	Impaired antibody response causes persistence of prototypic T cell-contained virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katja Fink Research Topics

Disease

30	Infections 01/2023 - 10/2003
22	Dengue (Dengue Fever) 01/2024 - 10/2009
8	Virus Diseases (Viral Diseases) 10/2023 - 09/2004
4	Viremia 12/2016 - 04/2009
3	Coinfection 12/2016 - 01/2011
3	Vesicular Stomatitis 01/2008 - 10/2003
2	Human Influenza (Influenza) 10/2023 - 08/2010
2	Zika Virus Infection 01/2023 - 04/2017
2	COVID-19 11/2020 - 01/2020
2	Yellow Fever 07/2020 - 11/2018
2	Flavivirus Infections 01/2019 - 01/2019
1	Neoplasms (Cancer) 10/2023
1	Major Depressive Disorder (Major Depressive Disorders) 10/2023
1	Communicable Diseases (Infectious Diseases) 05/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2021
1	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 11/2018
1	Japanese Encephalitis 11/2018
1	Inflammation (Inflammations) 09/2014
1	Fever (Fevers) 01/2011
1	Reinfection 10/2008
1	Persistent Infection 10/2008
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 09/2004

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 05/2023 - 09/2004
13	AntibodiesIBA 05/2023 - 01/2008
10	Neutralizing AntibodiesIBA 01/2021 - 09/2004
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2012
7	Immunoglobulin G (IgG)IBA 03/2015 - 10/2003
5	CytokinesIBA 01/2019 - 10/2009
4	Antiviral Agents (Antivirals)IBA 01/2019 - 02/2014
4	InterferonsIBA 01/2019 - 01/2017
3	Dengue VaccinesIBA 01/2019 - 07/2014
3	Immunoglobulin M (IgM)IBA 04/2009 - 10/2003
2	Broadly Neutralizing AntibodiesIBA 01/2024 - 09/2012
2	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2019
2	AntigensIBA 10/2023 - 12/2019
2	ChemokinesIBA 01/2022 - 01/2012
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2014
2	Subunit VaccinesIBA 01/2019 - 01/2019
2	Interferon-gamma (Interferon, gamma)IBA 07/2014 - 08/2010
2	triphosphoric acid (triphosphate)IBA 04/2014 - 02/2014
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2024
1	Amino Acids FDA Link 01/2024
1	Transcription Factors (Transcription Factor)IBA 01/2024
1	Ketamine FDA LinkGeneric 10/2023
1	Anesthetics (Anesthetic Agents)IBA 10/2023
1	4- (2- (4- isopropylbenzamido)ethoxy)benzoic acidIBA 01/2023
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 05/2021
1	nanolucIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Peptides (Polypeptides)IBA 12/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2019
1	EpitopesIBA 12/2019
1	LigandsIBA 01/2019
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2019
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 04/2017
1	Monoclonal AntibodiesIBA 04/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017
1	Recombinant Fusion ProteinsIBA 03/2015
1	Capsid Proteins (Capsid Protein)IBA 03/2015
1	aluminum sulfate (alum)IBA 03/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2014
1	Phosphotransferases (Kinase)IBA 10/2014
1	Interleukin-10 (Interleukin 10)IBA 09/2014
1	Interferon Type IIBA 07/2014
1	CytidineIBA 02/2014
1	balapiravirIBA 02/2014
1	4'-azidocytidineIBA 02/2014
1	ProdrugsIBA 02/2014
1	Viral ProteinsIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Aluminum Oxide (Sapphire)IBA 12/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Interleukin-15 (Interleukin 15)IBA 08/2010
1	HLA-DR Antigens (HLA-DR)IBA 08/2010
1	Liposomes (Liposome)IBA 10/2009
1	Clodronic Acid (Clodronate)IBA 10/2009
1	Immunoglobulin A (IgA)IBA 10/2008
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2003

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Aftercare (After-Treatment) 02/2014
1	Immunotherapy 04/2009